AVONEX
- Product NDC
- 59627-111
- 11-digit product format
- 596270111
- Labeler code
- 59627
- Product ID
- 59627-111_ab554941-0dbb-4416-981d-10bf8f8a136c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- interferon beta-1a
- Dosage form
- KIT
- Route
- INTRAMUSCULAR
- Labeler
- Biogen Inc.
- Application
- BLA103628
- Marketing category
- BLA
- Marketing start
- 2014-08-29
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59627-111-03 | EA - Each | 59627-111 | e8ed3fd0-ff87-41bf-a1eb-95ea038bc858 | 1 | 2015-04-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Avonex | INTERFERON BETA-1A | Biogen Inc. | d70a39cc-de15-4c12-a1ec-8063b69ea0e1 | 2025-11-19 | Warnings, Adverse reactions | BLA103628 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 103628 | Avonex | interferon beta-1a | 351(a) | Disc | 2026-09-01 |